A government advisory panel is discussing which schoolchildren should get Pfizer's pediatric COVID-19 vaccine. The FDA last week OK'd the use of kid-size doses for children ages 5 to 11, but the CDC also must sign off before vaccinations begin. (Nov. 2)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Instagram: https://www.instagram.com/APNews/
​

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/a5d068b2d1194aac91c625314e579997